Sponsor Pipeline

Sling Therapeutics, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
2
Recruiting
3
Phase 3
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-08-07 NCT07753603 Study to Assess Linsitinib in Participants With Moderate to Severe Active Thyroid Eye… Phase 3 Recruiting
Active Trials by Phase
Phase 3
1
Phase 2/3
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07753603 Study to Assess Linsitinib in Participants With Moderate to Severe Active Thyroid Eye… Thyroid Eye Disease, TED Recruiting
Phase 2/3
NCT06112340 Extension Study of Two Doses of Linsitinib in Subjects With Active, Moderate to Severe… Thyroid Eye Disease Recruiting
NCT05276063 A Phase 2b, Study of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye… Thyroid Eye Disease Active, Not Recruiting
Get alerts when Sling Therapeutics, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free